AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04825756 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Manualized equine assisted therapy
Description: This equine assisted therapy (EAT), which is delivered in a group setting, combines therapeutic horseback riding with cognitive behavioral strategies for anxiety. Each 45 minute session is delivered in a group format with up to four children between 6 and 17 years of age. Each session follows the same structure: (1) weekly review; (2) groom and connect; (3) warm-up period; (4) session activity; (5) cool down; (6) parent/caregiver psychoeducation, during which the instructor facilitates psychoeducation; and (7) homework instruction.
Study NCT03924102 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
Description: A rest and stress imaging study will be conducted on the PET/CT scanner with \[11C\] Acetate.
Study NCT04724447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valganciclovir
Description: 2 x 450mg VGCV tablets
Study NCT04724447 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo equivalent of 900mg/day VGCV
Study NCT06078644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: respiratory exercise diary
Description: Patients in the intervention group will be asked to perform breathing exercises in the form of using a spirometer 10 times every hour during the preoperative period while they are awake for three days, starting from the first day after the surgery. Patients in this group will be given a breathing exercise diary.
Study NCT05050786 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Negative Wound Pressure Therapy (Prevena(TM))
Description: After skin closure, NPWT in the form of Prevena™ (KCI/Acelity, San Antonia, TX, USA) is applied using the following technique: The sterile foam dressing is removed from the package and placed on the incision in the entire length, on top of which the sterile dressing is placed, ensuring air tightness. An appropriate hole in the dressing is cut at the center of the dressing and the tube for the interface pad is connected and a negative pressure of 125mmHg is applied. The Prevena™ system is removed on the morning of postoperative day 3.
Study NCT05050786 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Wound Dressing
Description: After skin closure, a standard operative dressing is applied in the entire length of the incision. This operative dressing is removed in the morning of postoperative day two. Only in the case of blood or serous fluid mandating changing of the dressing, will this be done prior to postoperative day 2.
Study NCT06439472 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital Inhibition Technique
Description: The researcher will place their palms under the patient's head and use their fingers to contact the occipital condyles. Next, the researcher will place the 3rd and 4th fingers of each hand in the space between the occiput and the spinous process of C2. The metacarpophalangeal joints are at 90º flexion, with the base of the skull resting on their hands while they apply constant, non-painful pressure in a postero-anterior direction, keeping the 2nd, 3rd and 4th fingers together in extension. Afterwards, the researcher applies a light and gentle traction in a cephalad direction in order to relieve the suboccipital area. Once the suboccipital muscles have relaxed, the researcher gently removes the contact, leaving the participant's head resting on the table.~This technique is performed for 4 minutes.
Study NCT06439472 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham Technique
Description: The participant is instructed to lie down in the supine position while the mediator assumes a position at the head of the table and places their hands on the participant's shoulders. This technique is performed for 4 minutes.
Study NCT05833646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group 1
Description: In each group, patients will be applied both standard subcutaneous heparin injection and with ShotBlocker.
Study NCT05833646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group 2
Description: In each group, patients will be applied both standard subcutaneous heparin injection and with virtual reality glasses.
Study NCT05833646 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group 3
Description: In each group, patients will be applied both standard subcutaneous heparin injection and with cold application.
Study NCT05431777 — intervention group
Intervention type: DRUG
Intervention: Avelumab
Description: As provided in real world setting
Study NCT06422442 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Threat-related stimulus exposure
Description: Participants will view threat-related stimuli (words or faces) paired with nonthreat matches in three related experimental paradigms.
Study NCT05215899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MINDFULNESS-BASED YOGA AND MEDITATION
Description: The application was carried out by the researcher who had completed mindfulness-based yoga and meditation training.
Study NCT06412562 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: The Maudsley 3-item Visual Analogue Scale (M3VAS)
Description: Patients will be asked to complete The Maudsley 3-item Visual Analogue Scale (M3VAS) and 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR-16).
Study NCT04642352 — intervention group
Intervention type: DRUG
Intervention: superior laryngeal nerve block
Description: A unilateral injection of 2 cc of a 1:1 mixture of 0.25% bupivacaine and Kenalog-40 via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) via a 27 gauge needle to the thyrohyoid space (front of neck, just above larynx/voice box) on the side which exhibited most discomfort/tenderness/cough on palpation. If neither side was uncomfortable, the right side will be used.
Study NCT05707910 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EBV immunological agent
Description: Low-dose group:2\*10\^7 Medium-dose group:5\*10\^7 High-dose group:2\*10\^8
Study NCT05500014 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofortified potato, not genetically modified
Description: Cooked potato, not genetically modified, with the addition of an acqueous solution of 57FeSO4 (3 mg in total).
Study NCT04792060 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hook plate
Description: We used titanium 2.4 mm hooked distal ulnar locked plate used for fixation of distal ulna fractures , this plate have low profile which is anatomically precontoured
Study NCT05719298 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory interface
Description: Application of the new interface and accessories and provision of non-invasive respiratory support through the device.
Study NCT05745753 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sample blood
Description: At the time of enrolment, peripheral blood sampling is expected at the outpatient clinic of the experimental center and the study of the patient's clinical history.
Study NCT05085470 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Schistosoma mansoni infection
Description: 20 viable male Schistosoma mansoni cercariae of the Puerto Rican strain
Study NCT05085470 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Schistosoma mansoni infection
Description: 20 viable male Schistosoma mansoni cercariae of the Puerto Rican strain
Study NCT05085470 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo mock infection
Description: Placebo mock infection with water
Study NCT05262751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ofev®
Description: Ofev®
Study NCT05262751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nintedanib formulation 1
Description: Nintedanib formulation 1: Monolithic Nintedanib Modified Release Tablet (MR1) as two Prototypes (MR1-1 and MR1-2).
Study NCT05262751 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nintedanib formulation 2
Description: Nintedanib formulation 2: Polyox Nintedanib Modified Release Tablet (MR2) as two Prototypes (MR2-1 and MR2-2).
Study NCT05595577 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise with Trainerize application
Description: 1-2 sessions per week consisting of slow 15 minute aerobic warm, 20 minutes of strength training, 15 minutes progressive intensity aerobic exercise and 10 minute cool down (stretching/toning) with elastic bands.
Study NCT05595577 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing
Description: Maximal peak VO2 (to monitor the body's oxygen consumption) and 6-minute exercise walking test.
Study NCT05595577 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI scan
Description: Images of the heart will be taken.
Study NCT05595577 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quality of Life Questionnaires
Description: Participants will be asked to complete several questionnaires that will measure fatigue, general health, social determinants of health, cognitive function (tasks that assess memory, ability to count, etc.) and physical activity. The questionnaires will take 15-40 minutes to complete.
Study NCT05595577 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive and Brain Function Questionnaires
Description: Participants will be asked to complete several questionnaires that will measure fatigue, general health, social determinants of health, cognitive function (tasks that assess memory, ability to count, etc.) and physical activity. The questionnaires will take 15-40 minutes to complete.
Study NCT05595577 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood draws
Description: Approximately 2 teaspoons of blood withdrawn from either a vein in your arm or a currently placed central line port-a-cath. A portion of blood from each visit will be used to collect information about blood cell count.
Study NCT05284630 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise follow up with mobile application
Description: Exercises will be followed by mobile application. Electrotherapy will be performed.
Study NCT05284630 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home-Based Exercise Program followed by paper booklet
Description: Exercise will be followed by paper booklet. Electrotherapy will be performed.
Study NCT05284630 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrotherapy
Description: Electrotherapy will be performed.
Study NCT05517226 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Cotadutide
Description: Participants will receive cotadutide subcutaneously.
Study NCT04366505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU) and neurofeedback (NFB)
Description: This group will receive Treatment as usual (TAU) and neurofeedback (NFB). During NFB, participants will be asked to regulate the signal from a target brain region during the presentation of alcohol cues. The ventral striatum was chosen as target region.
Study NCT04366505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness-based relapse prevention (MBRP) and NFB
Description: This group will receive MBRP and neurofeedback (NFB). MBRP consists of 5 extensive sessions of a specific manualized mindfulness-based intervention for alcohol dependent patients which will be carried out by trained psychologists and psychotherapists. During NFB, participants will be asked to regulate the signal from a target brain region during the presentation of alcohol cues. The ventral striatum was chosen as a target region.
Study NCT04366505 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU and sham NFB
Description: This group will receive TAU and sham NFB. Sham NFB means that the signal displayed to the participant is based on activity in a control region, the auditory cortex, which is not involved in cue reactivity.
Study NCT04366505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBT and sham NFB
Description: This group will receive MBRP and sham NFB. MBRP consists of 5 extensive sessions of a specific manualized mindfulness-based intervention for alcohol dependent patients which will be carried out by trained psychologists and psychotherapists. Sham NFB means that the signal displayed to the participant is based on activity in a control region, the auditory cortex, which is not involved in cue reactivity.
Study NCT05017077 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DynaVision System
Description: Telemonitoring for pediatric heart failure
Study NCT06198972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Pnf exercises
Description: Exercise Frequency 3 days/week Exercise Intensity 60% of 1 maximum repetition Exercise Duration: 5-minute warm-up 20 minutes (2 sets of 15 repetitions) exercise training 5 min cool down Exercise Type Pelvic patterns~* Anterior elevation-Posterior depression~* Anterior depression-Posterior elevation PNF techniques~* Repetitive stretching~* Rhythmic stabilization
Study NCT06198972 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Strength exercises
Description: 3 days/week 60% of 1 repetition maximum 5 minute warm up 20 min exercise training 5 min cool down Lower extremity movements~* Hip flexion~* Hip extension~* Hip abduction~* Hip adduction~* Knee flexion~* Knee extension Resistance exercise training
Study NCT05447234 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tcrx T cell
Description: Sequential IV infusion
Study NCT04682379 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Proprioceptive assessment
Description: 1. Trunk flexion-extension repositioning test~2. Trunk lateral-flexion repositioning test~3. Trunk axial-rotation repositioning test~4. Neck rotation repositioning test~5. Elbow flexion repositioning test~6. Knee extension repositioning test
Study NCT03885245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-ctirulline
Description: 7 weeks of treatment with 15 g/day of orally administered (powder form mixed with water) L-citrulline
Study NCT03885245 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: 7 weeks of treatment with orally administered matching placebo (to 15 g/day of L-citrulline)
Study NCT05212753 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: Hot packs or hot water bags are superficial warming agents that will be used to heat muscle tissue, reduce muscle spasms and pain sensation. TENS is a pain reliever application.
Study NCT05212753 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar stabilization exercises
Description: Training about the concepts of stabilization and abdominal bracing is given before starting the study. The motor control tests for local muscles transversus abdominus and multifidi are performed after the training. The abdominal bracing test is performed in the quadruped position, in prone, and in hook lying position with the patient's spine supine with hips and knees flexed and knees in contact with the surface. The second stage consists of closed-chain segmental control exercises. It is a series of weight-bearing exercises are performed on stable and unstable surfaces. The last stage of the stabilization program is an open kinetic chain exercise to promote distal stability.
Study NCT05212753 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing exercises
Description: Breathing exercises consist of the techniques of diaphragmatic and pursed-lip breathing. During diaphragmatic breathing, attention is focused on the correct abdominal breathing. The pursed-lip breathing is one step further to the diaphragmatic breathing and a technique designed to have control time and volume over-breathing. This intervention also includes Sleep Hygiene education to the subjects,
Study NCT05788692 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electric tootbrush
Description: Participants will brush twice per day with an electric toothbrush
Study NCT05788692 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: manual toothbrush
Description: Participants will brush twice per day with a manual toothbrush
Study NCT05788692 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: toothbrushing assisting application
Description: Participants will brush twice per day with toothbrushing assisting application
Study NCT05613153 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Peppermint Oil
Description: Participants weighing more than 40 kg will receive 2 peppermint oil capsules 3 times a day. Smaller children who weigh between 30 kg and 40 kg will receive 1 capsule of peppermint oil 3 times a day. All subjects will receive 8 weeks of treatment.
Study NCT06227221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib
Description: Subjects receive sorafenib 400mg once daily. Insulin therapy will be continued as a routine therapy.
Study NCT06227221 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects receive placebo 400mg once daily. Insulin therapy will be continued as a routine therapy.
Study NCT04592159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nabiximols
Description: oromucosal spray
Study NCT04592159 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: oromucosal spray
Study NCT05573633 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ECG
Description: the POAF will be diagnosed using a 12-lead ECG and according to the usual monitoring protocols for patients in the cardiac surgery department of Amiens University Hospital.
Study NCT05573633 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: scanwatch
Description: POAF will be diagnosed with a Withings SM (ScanWatch). FAPO diagnosed by the SW will have to be confirmed by a 12-lead ECG.
Study NCT05987254 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: suprainguinal fascia iliaca block
Description: ultrasound guided suprainguinal fascia iliaca block
Study NCT05987254 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pericapsular nerve group block
Description: ultrasound guided pericapsular nerve group block
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitafloxacin
Description: In our Intervention group, sitafloxacin replace the ethambutol, 200mg/d
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SMZ/TMP
Description: In our The three-month Rifapentine\&Isoniazid\&Pyrazinamide\&Sitafloxacin\&SMZ/TMP-containing regimen, Six weeks of daily treatment with rifapentine, isoniazid, pyrazinamide, and Sitafloxacin, followed by seven weeks of daily treatment with rifapentine, isoniazid, ,SMZ/TMP and Sitafloxacin, SMZ 80mg/kg/d, TMP16mg/kg/d
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifampin
Description: Rifampin is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, Rifampin 600mg (8-12mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pyrazinamide
Description: Pyrazinamide is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, 2000mg (20-30mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrazinamide
Description: Pyrazinamide is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, 2000mg (20-30mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifapentine
Description: In our Intervention group, rifapentine replace rifampin, 600mg/d
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifapentine
Description: In our Intervention group, rifapentine replace rifampin, 600mg/d
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isoniazid
Description: Isoniazid is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, 300mg (4-6mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isoniazid
Description: Isoniazid is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, 300mg (4-6mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ethambutol
Description: Ethambutol is a first-line antimicrobial agent against drug-susceptible tuberculosis in WHO guideline, 1200mg (15-25mg/kg/d)
Study NCT05454345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: Moxifloxacin is a fourth-generation fluoroquinolone with potent activity against M. tuberculosis in vitro and in vivo, 400mg (7.5-10mg/kg/d)
Study NCT04626349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FOCUS+ (face-to-face nurse-led intervention)
Description: Home-based psycho-educational intervention consisting of two 90-minute home visits and one 30-minute video-conferencing session, conducted by a trained intervention nurse over a period of 12 weeks (4 weeks between each session).~The intervention is comprehensively manualized and there is a protocol to guide delivery of the intervention for each home visit and video call. The content of the sessions is always tailored to the needs of the dyads, so certain topics can be discussed more in-depth and specific information can be shared. The nurses who will deliver the FOCUS+ intervention will receive an extensive online training and additional continuous follow-up training to provide them with the knowledge and skills required to successfully implement the intervention. A FOCUS+ core booklet is provided as a supporting guide for the dyads that they can refer to at their own discretion and reinforces key intervention messages linked to the core components of the intervention.